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Introduction:  Variceal  bleeding  (VB)  is  a  serious  complication  in  cirrhotic  patients.  Hepatic
pressure venous  gradient  (HPVG)  is  the  gold  standard  to  assess  high  risk  of  VB,  but,  this  is  not
always available  and  is  an  invasive  method.  Therefore  is  necessary  to  explore  if  non-invasive
parameters  are  useful  as  predictive  factors  of  high  risk  of  VB.
Objective:  To  evaluate  if  low  platelet  count,  spleen  size,  platelet  count/spleen  size  ratio,
portal vein  diameter,  blood  ﬂow  velocity  of  the  portal  vein,  congestion  index  of  the  portal  vein,
and variceal  size  could  be  useful  as  non-invasive  parameters  for  predicting  high  risk  of  VB  in
cirrhotic  patients.
Subjects  and  methods:  Observational,  cross  sectional  study,  that  includes  99  cirrhotic  patients
with esophageal  varices.  For  predictive  analysis  we  considered  as  the  dependent  variable
‘‘presence  of  VB’’  and  the  independent  variables  we  tested  were:  Child-Pugh  score,  platelet
count, spleen  size,  portal  vein  diameter,  platelet  count/spleen  size  ratio,  blood  ﬂow  velocity  of
the portal  vein,  congestion  index  of  the  portal  vein,  variceal  size.  Univariate  and  multivariate
logistic regression  were  performed.
Results:  99  cirrhotics  with  esophageal  varices  were  included,  56  (56.6%)  were  female,  the  mean
of age  was  57.8  ±  12.2.  About  variceal  size,  54  (54.5%)  of  patients  had  large  varices.  Regarding
to occurrence  of  VB,  46  (46.5%)  presented  it.  In  the  multivariate  analysis,  the  presence  of  large
varices in  the  endoscopic  study  was  the  best  predictor  of  VB  (OR  =  11.1;  95%  CI  =  3.9  to  32.8,
P <  0.0001).  Portal  vein  diameter  ≥  13  mm  results  with  an  OR  =  5.0;  95%  CI  =  1.1  to  21.7,  P  =  0.03
Conclusions:  The  presence  of  large  esophageal  varices  is  the  most  important  predictive  risk
factor for  the  occurrence  of  VB,  independently  of  the  class  of  Child-Pugh.  Additionally,  the
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portal  vein  diameter  ≥  13  mm  is  a  non-invasive  parameter  related  to  high  risk  of  VB.  Therefore,
these factors  could  be  used  as  predictors  of  high  risk  of  VB  when  the  measure  of  HPVG  is  not
available.
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Parámetros  no  invasivos  como  predictores  de  alto  riesgo  de  hemorragia  variceal  en
pacientes  cirróticos
Resumen
Introducción:  La  hemorragia  variceal  (HV)  es  una  complicación  grave  en  pacientes  cirróticos.
El gradiente  de  presión  venosa  hepática  (GPVH)  es  el  estándar  de  oro  para  clasiﬁcar  pacientes
con alto  riesgo  de  HV,  sin  embargo,  este  no  siempre  está  disponible  y  es  un  método  invasivo.
Por tanto,  es  necesario  explorar  si  parámetros  no  invasivos  son  útiles  como  factores  predictores
de alto  riesgo  de  HV.
Objetivo:  Evaluar  si  la  baja  cuenta  plaquetaria,  taman˜o  del  bazo,  cociente  cuenta  plaque-
taria/taman˜o del  bazo,  diámetro  portal,  velocidad  del  ﬂujo  portal,  índice  de  congestión  portal,
y taman˜o  variceal  podrían  ser  útiles  como  parámetros  no  invasivos  para  predecir  alto  riesgo  de
HV en  pacientes  cirróticos.
Sujetos  y  métodos: Estudio  observacional,  transversal,  que  incluyó  99  pacientes  cirróticos  con
varices esofágicas.  Para  el  análisis  predictivo  consideramos  como  la  variable  dependiente
‘‘presencia de  HV’’,  y  como  variables  independientes:  estadio  de  Child-Pugh,  cuenta  pla-
quetaria, taman˜o  del  bazo,  diámetro  portal,  cociente  cuenta  plaquetaria/taman˜o  del  bazo,
velocidad del  ﬂujo  portal,  índice  de  congestión  portal,  taman˜o  variceal.  Realizamos  análisis  de
regresión  logística  uni  y  multivariado.
Resultados:  Se  incluyeron  99  pacientes  cirróticos  con  varices  esofágicas,  56  (56.6%)  fueron
mujeres, la  media  de  edad  fue  57.8  ±  12.2.  Respecto  al  taman˜o  variceal,  54  (54.5%)  tuvieron
varices grandes.  Respecto  a  la  ocurrencia  de  HV,  46  (46.5%)  la  presentaron.  En  el  análisis  multi-
variado, la  presencia  de  varices  grandes  por  endoscopia  fue  el  mejor  predictor  de  HV  (RM  =  11.1;
IC 95%  =  3.9  a  32.8,  P  <  0.0001).  El  diámetro  portal  resultó  con  una  RM  =  5.0;  IC  95%  =  1.1  to  21.7,
P =  0.03.
Conclusiones:  La  presencia  de  varices  esofágicas  grandes  es  el  factor  predictivo  más  impor-
tante de  la  ocurrencia  de  HV,  independiente  de  la  clase  de  Child-Pugh.  Adicionalmente,  el
diámetro portal  ≥  13  mm  es  un  parámetro  no  invasivo  relacionado  con  alto  riesgo  de  HV.  Por
tanto, estos  factores  podrían  ser  utilizados  como  predictores  de  alto  riesgo  de  HV  cuando  en
GPVH no  este  disponible.
© 2014  Sociedad  Médica  del  Hospital  General  de  México.  Publicado  por  Masson  Doyma  México























ortal  hypertension  is  a  progressive  complication  of  cir-
hosis.  Portal  hypertension  leads  to  the  formation  of
orto-systemic  collaterals.  Gastroesophageal  varices  are  the
ost  relevant  porto-systemic  collaterals  because  their  rup-
ure  results  in  variceal  bleeding  (VB),  the  most  common
ethal  complication  of  cirrhosis,  associated  with  a  mortality
f  at  least  20%  at  6  weeks.1--4
The  most  important  predictor  of  variceal  bleeding  is
he  variceal  size,  with  the  highest  risk  of  ﬁrst  hemorrhage
bout  15%  per  year  occurring  in  patients  with  large  varices.
ther  predictors  of  hemorrhage  are  decompensated  cirrho-





tNowadays,  the  gold  standard  for  assessing  portal  pres-
ure  is  the  hepatic  venous  pressure  gradient  (HVPG),  which
s  obtained  by  determining  the  wedged  hepatic  venous  pres-
ure  (WHVP)  by  placing  a  catheter  in  the  hepatic  vein  and
y  inﬂating  a  balloon  and  occluding  a larger  branch  of  the
epatic  vein,  then  the  WHVP  is  corrected  for  increases  in
ntraabdominal  pressure  by  subtracting  the  free  hepatic  vein
ressure  (FHVP)  or  the  intraabdominal  inferior  vena  cava
ressure.6
The  HVPG  have  predictive  value  for  the  development  of
astroesophageal  varices,7,8 and  the  risk  of  VB.9--11 Patients
ith  an  HVPG  ≥  20  mmHg  (measured  within  24  hours  of  VB)
ave  been  identiﬁed  as  being  at  a higher  risk  for  early  recur-
ent  bleeding  within  the  ﬁrst  week  of  admission  or  failure































wNon-invasive  parameters  of  variceal  bleeding  
to  those  with  lower  pressure.12,13 Late  rebleeding  occurs  in
approximately  60%  of  untreated  patients,  mostly  within  1-2
years  of  the  index  hemorrhage.14,15 Limitations  to  the  gen-
eralized  use  of  HVPG  measurement  are  the  lack  of  local
expertise  and  poor  adherence  to  guidelines  that  will  ensure
reliable  and  reproducible  measurements,6 as  well  as  its  inva-
sive  nature.1 Furthermore,  is  expensive  and  not  always  is
available.  For  this  reason,  is  very  important  to  search  for
non-invasive,  accessible,  easy  to  perform,  and  reproducible
parameters  that  can  help  us  to  identify  patients  with  high
risk  of  bleeding.
Many  studies  have  evaluated  non-invasive  methods  such
as,  low  platelet  count,  spleen  size,  portal  vein  diame-
ter,  platelet  count/spleen  size  ratio,  and  they  seem  to  be
predictors  related  to  the  presence  of  large  or  high  grade
esophageal  varices.16--32 However,  there  is  not  sufﬁcient
information  about  if  these  non-invasive  parameters  could
be  used  as  reliable  predictors  of  high  risk  of  VB  that  avoid
the  need  for  HVPG.
The  aim  of  this  study  was  to  evaluate  if  low  platelet
count,  spleen  size,  platelet  count/spleen  size  ratio,  por-
tal  vein  diameter,  blood  ﬂow  velocity  of  the  portal  vein,
congestion  index  of  the  portal  vein,  and  variceal  size  could
be  useful  as  non-invasive  parameters  for  predicting  a  high
risk  of  VB  in  cirrhotic  patients.
Subjects and methods
Study  design
Observational,  cross  sectional  study  conducted  since  Febru-
ary  2011  to  February  2013,  including  cirrhotic  patients  for
any  etiology,  with  portal  hypertension  and  presence  of
esophageal  varices  documented  by  an  endoscopic  study.
Patients  with  portal  hypertension  with  a  prehepatic  or
posthepatic  origin,  previous  therapy  with  transjugular  intra-
hepatic  porto-systemic  shunts,  or  with  history  of  chirurgic
derivation  of  the  portal  vein,  spleenectomy,  thrombosis  or
cavernomatosis  of  the  portal  vein,  or  with  diagnosis  of  hep-




Table  1  Univariate  analysis  comparing  characteristics  between  c
Variable  Cirrhotic  patie
variceal  bleedi
n  =  46
Child-Pugh
A  21  (45.6)  
B 19  (41.3)  
C 6  (13.1)  
Platelet count  (cell/103)  104.1  ±  44.2  
Spleen size  (cm)  13.6  ±  2.6  
Portal diameter  (mm)  12.9  ±  2.5  
Platelet count/spleen  size  ratio  820.5  ±  445.4  
Blood ﬂow  velocity  of  the  portal  vein  (cm/seg)  18.2  ±  5.7  
Congestion index  of  the  portal  vein  0.135  ±  0.51  
Variceal size  (Large)  38  (38.4)  
Qualitative variables are expressed as frequency and percent. Numeric181
Esophageal  varices  were  classiﬁed  according  to  Baveno  V
onsensus33 in  small  or  large  varices.  We  searched  for  pres-
nce  or  absence  of  VB.  Also  patients  must  have  a  hepatic
oppler  ultrasound  and  laboratory  tests  to  determine  Child-
ugh  score,  and  also  platelet  count,  these  studies  must  have
een  performed  with  no  more  than  three  months  of  differ-
nce  regarding  to  the  endoscopic  study.  Hepatic  doppler
ltrasound  was  performed  with  a  Siemens  Acuson  S2000
quipment  with  a  convex  multi-frequency  transductor  by  an
xpert  radiologist,  the  following  measures  were  performed:
ortal  vein  diameter,  blood  ﬂow  velocity  of  the  portal  vein,
pleen  size  (spleen  longitudinal  axis  in  centimeters),  and
ith  these  parameters,  were  calculated  the  congestion
ndex  of  the  portal  vein,  and  platelet  count/spleen  size  ratio
ccording  to  the  next  formulas:
Congestion  index  of  the  portal  vein  =  cross-sectional  area
f  the  portal  vein  (cm2)/blood  ﬂow  velocity  of  the  portal
ein  (cm/sec)
Platelet  count/spleen  size  ratio  =  platelet  count
cell/103)/spleen  size  (mm)
tatistical  analysis
he  distribution  of  numerical  variables  were  analyzed  with
olmogorov-Smirnov  test,  in  case  of  non-normal  distribu-
ion,  logarithmic  base  10  transformation  was  performed  to
llowed  expressed  the  variables  as  mean  and  standard  devia-
ion  (SD).  Qualitative  variables  were  expressed  as  proportion
nd  percentage.  For  predictive  analysis  we  considered  as  the
ependent  variable  ‘‘presence  of  VB’’  and  the  independent
ariables  we  tested  were:  Child-Pugh  score,  platelet  count,
pleen  size,  portal  vein  diameter,  platelet  count/spleen  size
atio,  blood  ﬂow  velocity  of  the  portal  vein,  congestion
ndex  of  the  portal  vein,  variceal  size.  Univariate  and  multi-
ariate  logistic  regression  were  performed.  A P  value  ≤  0.05
as  considered  signiﬁcant.  SPSS  version  19.0  was  employed.esults
e  included  99  cirrhotic  patients  with  esophageal  varices
videnced  by  endoscopic  study,  56  (56.6%)  were  female,  and
irrhotic  patients  with  and  without  variceal  bleeding.
nts  with
ng
Cirrhotic  patients  without
variceal  bleeding
n  =  53
P
25  (47.1)  NS
22  (41.6)
6  (11.3)
120.7  ±  72.6  NS
12.4  ±  2.9  0.04
11.3  ±  3.3  0.01
1061.1  ±  744.7  0.05
20.8  ±  8.5  NS
0.109  ±  0.60  0.02
16  (16.2)  <  0.0001
al variables are expressed as mean and standard deviation.
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Table  2  Multivariate  analysis  to  determine  predictive  non-
invasive  parameters  for  high  risk  of  variceal  bleeding.
Variable  OR  (95%  CI)  P
Variceal  size(Large)  11.1  (3.9  --  32.8)  <  0.0001
Portal  vein  diameter
(≥  13  mm)
5.0  (1.1  --  21.7)  0.03
Spleen size  (≥  13.5
cm)
1.0  (0.9  --  1.3)  NS
Platelet  count/spleen
size  ratio  (≤  909)
1.0  (0.9  --  1.0)  NS
Congestion  index  of
the  portal  vein  (>
0.135)




























































aOR = Odds ratio.
95% CI = 95% Conﬁdence interval.
3  (43.4%)  were  male.  The  mean  of  age  was  57.8  ±  12.2.
ccording  to  Child-Pugh  score,  46  (46.5%)  were  Child-Pugh
,  41  (41.4%)  were  Child-Pugh  B  and  12  (12.1%)  were  Child-
ugh  C.  Chronic  alcohol  intake  was  the  most  common  cause
f  cirrhosis  counting  for  43  (43.4%)  patients,  followed  by
on-alcoholic  steatohepatitis  in  20  (20.2%)  patients,  16
16.2%)  patients  with  chronic  viral  hepatitis,  14  (14.1%)
atients  with  cryptogenic  cirrhosis,  and  6  (6.1%)patients
ith  an  autoimmune  origin.  About  variceal  size,  54  (54.5%)
f  patients  had  large  varices  and  45  (45.5%)  had  small
arices.  Regarding  to  occurrence  of  VB,  46  (46.5%)  presented
t,  and  53  (53.5%)  did  not.
When  we  compared  the  characteristics  between  cirrhotic
atients  with  VB  and  patients  without  VB,  we  found  dif-
erences  between  groups  regarding  to  spleen  size,  portal
iameter,  platelet  count/spleen  size  ratio,  congestion  index
f  the  portal  vein,  and  variceal  size  (see  Table  1).  However,
n  the  multivariate  analysis,  the  presence  of  large  varices  in
he  endoscopic  study  was  the  best  predictor  of  VB  (OR  =  11.1;
5%  CI  =  3.9  to  32.8,  P  <  0.0001)  (see  Table  2).
When  we  evaluated  non-invasive  parameters:  Child-Pugh
core,  platelet  count/spleen  size  ratio,  spleen  size,  portal
ein  diameter,  portal  vein  congestion  index,  as  predic-
ive  factors  of  the  presence  of  large  esophageal  varices,
e  found  that  all  of  them,  with  exception  of  Child-Pugh




Table  3  Univariate  analysis  comparing  characteristics  between  ci
Variable  Cirrhotic  patien
esophageal  var
Child-Pugh
A  20  (37)  
B 27  (50)  
C 7  (13)  
Platelet count  (cell/103)  101.2  ±  52.0  
Spleen size  (cm)  13.6  ±  2.9  
Portal diameter  (mm)  12.8  ±  3.0  
Platelet count/spleen  size  ratio  802.2  ±  500.7  
Blood ﬂow  velocity  of  the  portal  vein  (cm/sec)  18.4  ±  7.5  
Congestion index  of  the  portal  vein  0.135  ±  0.6  
Qualitative variables are expressed as frequency and percent. NumericM.A.  Pen˜aloza-Posada  et  al.
sophageal  varices.  The  best  predictive  factor  for  presence
f  large  esophageal  varices  was  platelet  count/spleen  size
atio  ≤  909  (OR  =  2.2;  95%  CI  =  1.3  to  1.8,  P  =  0.003)  (see
ables  3  and  4).
iscussion
B  is  one  of  the  most  serious  complications  of  the  portal
ypertension  in  cirrhotic  patients.1 To  assess  the  degree
f  portal  hypertension  in  patients  with  cirrhosis,  the  gold
tandard  is  the  measurement  of  HVPG.1,6 Gastroesophageal
arices  develops  in  patients  with  a  HVPG  > 10  mmHg,  those
ith  an  HVPG  >  12  mmHg  are  at  risk  of  VB,  and  those  with
n  HVPG  >  20  mmHg  are  at  high  risk  of  rebleeding  in  the  ﬁrst
4  hours  after  a  ﬁrst  episode  of  hemorrhage.1--13 According
o  several  studies,1,5,7,30--33 variceal  size  is  one  of  the  most
mportant  predictive  risk  factors  for  VB.  In  our  study,  we
orroborate  that  the  presence  of  large  esophageal  varices
s  the  main  independent  predictive  risk  factor  for  VB  in  cir-
hotic  patients,  despite  of  the  class  of  Child-Pugh.  However,
s  important  to  note  that  in  our  study  most  of  patients  were
lassiﬁed  as  Child-Pugh  A  and  B,  only  a  few  patients  were
lassiﬁed  as  Child-Pugh  C.  Other  studies  have  found  that
hild-Pugh  B/C  patients  have  the  greatest  risk  for  develop
arge  esophageal  varices  and  VB.1,34,35
Several  previous  studies  have  shown  independent  param-
ters  like  splenomegaly,34,36--39 low  platelet  count,34,37--39
ortal  vein  diameter, 34,40 platelet  count/spleen  diameter
atio,34,41,42 congestion  index  of  the  portal  vein 43 as  sig-
iﬁcant  predictors  for  the  presence  of  esophageal  varices.
n  our  study,  we  also  found  that  spleen  size,  platelet
ount/spleen  size  ratio,  portal  vein  diameter,  spleen  size
nd  congestion  index  of  the  portal  vein  were  independent
redictors  for  the  presence  of  large  esophageal  varices
P  =  0.01),  low  platelet  count  was  also  found  in  patients
ith  large  esophageal  varices  (P  =  0.04).  However,  when  we
valuated  these  non-invasive  parameters  as  predictors  of
igh  risk  of  VB,  only  the  portal  vein  diameter  ≥  13  mm  was
 predictive  factor  (P  =  0.03)  according  to  our  multivariate
nalysis.
Primary  prophylaxis  to  prevent  the  ﬁrst  VB  is  indicated
n  cirrhotic  patients  with  large  varices,  either  non-selective
eta-blockers  (NSBB)  or  endoscopic  variceal  ligation  (EBL)
rrhotic  patients  with  large  and  with  small  esophageal  varices.
ts  with  large
ices  n  =  54
Cirrhotic  patients  with  small
esophageal  varices  n  =  45
P
26  (57.8)  NS
14  (31.1)
5  (11.1)
127.1  ±  69.0  0.04
12.2  ±  2.4  0.01
11.2  ±  3.0  0.01
1125.8  ±  728.2  0.01
21.0  ±  7.2  NS
0.105  ±  0.5  0.01
al variables are expressed as mean and standard deviation.
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Table  4  Multivariate  analysis  to  identify  predictive  non-invasive  parameters  for  presence  of  large  esophageal  varices  in  cirrhotic
patients.
Variable  Small  varices  n  =  45  (%)  Large  varices  n  =  54  (%)  P  OR  (95%  CI)
Platelet  count/spleen  size  ratio  (≤909)  21  (46)  41  (75)  0.003  2.2  (1.3  a  3.8)
Spleen size  (≥  13.5cm)  14  (31)  30  (55)  0.02  1.6  (1.1  a  2.2)
Portal vein  diameter  (≥13mm)  14  (31)  29  (53)  0.02  1.5  (1.1  a  2.1)






1OR = Odds ratio; 95% CI = 95% conﬁdence interval.
can  be  used.44 The  advantages  of  NSBB  are  that  their  cost
is  low,  expertise  is  not  required  for  their  use,  and  they
may  prevent  other  complications,  such  as  bleeding  from
portal  hypertensive  gastropathy,  ascites,  and  spontaneous
bacterial  peritonitis  because  they  reduce  portal  pressure.
Additionally,  many  patients  prefer  to  avoid  endoscopic  pro-
cedures  because  of  their  invasive  nature.45 Since  our  study
corroborates  that  non-invasive  ultrasonographic  parameters
are  capable  to  identify  patients  with  large  varices,  and  large
varices  are  a  main  risk  factor  for  VB,  we  propose  that  in
selected  patients,  or  when  endoscopy  is  not  available,  non-
invasive  ultrasonographic  parameters  could  be  enough  to
decide  start  primary  prophylaxis  with  NSBB.
A  limitation  of  our  study  is  its  retrolective  character.  Fur-
thermore,  in  our  institution  we  do  not  count  with  equipment
to  perform  HPVG,  therefore  we  could  not  determine  it  in
our  patients,  as  we  did  not  count  with  the  gold  standard
to  prognosis  the  risk  of  VB  we  considered  inappropriate  to
determine  the  sensibility,  speciﬁcity,  and  predictive  values
for  variceal  size  and  portal  vein  diameter  as  tools  for  predict
high  risk  of  VB  in  cirrhotic  patients.
Prospective  studies  to  evaluate  the  non-invasive  param-
eters  proposed  in  this  study  are  necessary  to  validate  our
ﬁndings.  Since  we  collected  the  ultrasonographic  data  from
medical  records,  we  had  not  the  opportunity  to  evaluate  the
inter-observer  concordance.
Conclusions
The  presence  of  large  esophageal  varices  is  the  most
important  predictive  risk  factor  for  the  occurrence  of  VB,
independently  of  the  class  of  Child-Pugh.  Additionally,  the
portal  vein  diameter  ≥  13  mm  is  a  non-invasive  parame-
ter  related  to  high  risk  of  VB.  Therefore,  presence  of  large
varices  and  a  portal  vein  diameter  ≥  13  mm  can  be  used  as
predictors  of  high  risk  of  VB  when  the  measure  of  HPVG  is  not
available.  However,  other  non-invasive  parameters  seem  to
be  not  useful  and  cannot  replace  the  determination  of  the
HPVG.
Our  study  conﬁrms  that  in  medical  centers  where  endo-
scopic  study  is  not  available,  non-invasive  parameters  such
as,  portal  vein  diameter  ≥  13  mm,  spleen  size  ≥  13.5  cm,
platelet  count/spleen  size  ≤  909,  and  the  portal  vein
congestion  index  >  0.135  could  be  useful  tools  to  predict  the
presence  of  large  esophageal  varices  in  cirrhotic  patients
independently  of  the  class  of  Child-Pugh.  The  most  use-
ful  of  them,  is  platelet  count/spleen  size  ratio.  Therefore,
these  parameters  could  guide  the  decision  to  start  primary
prophylaxis.
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